Comparative effects of lisinopril and losartan on insulin sensitivity in the treatment of non diabetic hypertensive patients (Q24683365)

2

0 references

L Corradi

3

0 references

P Lazzari

4

0 references

A Mugellini

5

0 references

P Lusardi

British Journal of Clinical Pharmacology

6

0 references

language of work or name

English

0 references

publication date

November 1998

0 references

published in

0 references

volume

46

0 references

issue

5

0 references

page(s)

467-71

0 references

cites work

Losartan potassium: a review of its pharmacology, clinical efficacy and tolerability in the management of hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873694

Clinical experience with angiotensin II receptor antagonists.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873694

Lisinopril. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873694

Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873694

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873694

Metabolic effects of kinins: historical and recent developments

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873694

Essential hypertension: an insulin-resistant state

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873694

Glucose clamp technique: a method for quantifying insulin secretion and resistance

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873694

Effects of losartan on insulin sensitivity in severe hypertension: connections through sympathetic nervous system activity?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873694

Effects of angiotensin receptor antagonist and angiotensin converting enzyme inhibitor on insulin sensitivity in fructose-fed hypertensive rats and essential hypertensives.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873694

Effects of angiotensin-converting enzyme inhibitors on glucose and lipid metabolism in essential hypertension

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873694

A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873694

ACE inhibition improves insulin-sensitivity in aged insulin-resistant hypertensive patients

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873694

Effect of angiotensin converting enzyme inhibitor (lisinopril) on insulin sensitivity and sodium transport in mild hypertension.

30 May 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.1998.00811.X

Improved insulin action and glycemic control after long-term angiotensin-converting enzyme inhibition in subjects with arterial hypertension and type II diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.1998.00811.X

The effect of enalapril with and without hydrochlorothiazide on insulin sensitivity and other metabolic abnormalities of hypertensive patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.1998.00811.X

Hypotensive effect of losartan, a nonpeptide angiotensin II receptor antagonist, in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.1998.00811.X

Hemodynamic and humoral effects of the angiotensin II antagonist losartan in essential hypertension

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873694

Effects of losartan on insulin sensitivity in hypertensive subjects

28 November 2018

1 reference

12 December 2020

Effect of acute and chronic losartan treatment on glucose tolerance and insulin sensitivity in fructose-fed rats

1 reference

12 December 2020

The effect of angiotensin II receptor antagonism with losartan on glucose metabolism and insulin sensitivity

1 reference

12 December 2020

Kinins contribute to the improvement of insulin sensitivity during treatment with angiotensin converting enzyme inhibitor

1 reference

12 December 2020